Eli Lilly & Co.

-$3.44 (-1.1%)
Closing price August 11, 2022
Friday’s top analyst upgrades and downgrades included Altice USA, AppLovin, Biogen, Bristol-Myers Squibb, Broadcom, Ciena, Cloudflare, Denison Mines, Diageo, Eli Lilly, Rio Tinto and Southwest...
Monday's top analyst upgrades and downgrades included Adobe, Anheuser-Busch, Baker Hughes, Chevron, Eli Lilly, Halliburton, Home Depot, Intuit, Microsoft, Robinhood Markets, Shopify, Sirius XM,...
Monday's top analyst upgrades and downgrades included Carvana, Cloudflare, Comcast, ConocoPhillips, Constellation Brands, Exxon Mobil, Eli Lilly, SoFi Technologies and Starbucks.
Wednesday's top analyst upgrades and downgrades included Boeing, Conagra Brands, Constellation Brands, Eli Lilly, Hess, HP, Lockheed Martin, Nike, Occidental Petroleum and Wingstop.
Thursday’s top analyst upgrades and downgrades included Avis Budget, Chewy, Danaher, Eli Lilly, Etsy, Fastly, Halliburton, Robinhood, Roku, Walmart and Western Digital.
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Tuesday, including Domino’s, Eli Lilly, Harley-Davidson, McDonald’s and Merck.
Here's a look at the latest analyst calls for Thursday, June 24.
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Eli Lilly is shuffling the executive deck on Tuesday after allegations about inappropriate communication arose against its chief financial officer.
IBM's lead director is the only one who can swing the company back in the right direction. If he sticks with current management, it will continue to be America's most troubled large tech company.
Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports expected this week.
Tuesday's top analyst upgrades and downgrades included Airbnb, American Express, Arch Capital, Carlyle, Darden Restaurants, Facebook, Eli Lilly and Nio.
These five top stocks from the Goldman Sachs Americas Conviction List for 2021 offer investors a degree of safety and total return potential. They sense for long-term growth investors looking to add...
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
Prevail Therapeutics shares absolutely exploded on Tuesday morning after it was announced that the company would be acquired by Eli Lilly.